CAS number：1234356-69-4 molecular formula：C29H29FN4O
Derazantinib(ARQ-087)是具有口服生物活性的FGFR抑制剂，对FGFR2、FGFR1、FGFR3的IC50分别为1.8 nM、4.5 nM和4.5 nM，对FGFR4的抑制活性较低，IC50为34 nM。它还能抑制RET、DDR2、PDGFRβ、VEGFR和KIT。 Derazantinib(ARQ-087) is an orally bioavailable inhibitor of the fibroblast growth factor receptor (FGFR) with IC50 values of 1.8 nM for FGFR2, and 4.5 nM for FGFR1 and 3, showing lower potency for FGFR4 (IC50=34 nM). It also inhibits RET, DDR2, PDGFRβ, VEGFR and KIT.
| Chinese alias | - | ||
| English alias | Benzo(H)quinazolin-2-amine, 6-(2-fluorophenyl)-5,6-dihydro-N-(3-(2-((2-methoxyethyl)amino)ethyl)phenyl)-, (6R)- | DB14889 | WHO 10488 | (6R)-6-(2-fluorophenyl)-N-[3-[2-(2-methoxyethylamino)ethyl]phenyl]-5,6-dihydrobenzo[h]quinazolin-2-amine | ARQ-087ARQ-0 | ||
| CAS number | 1234356-69-4 | molecular formula | C29H29FN4O |
| molecular weight | 468.57 g/mol | Exact mass | - |
| PSA | 59.100 Ų | logp | 5.3 |
No numbering system information yet
No physical and chemical property information yet
No production method and use information yet
No upstream information yet
No downstream information yet
